Liver cancer, a life-threatening condition, poses significant challenges worldwide, requiring targeted and innovative treatments for effective outcomes.
Details →
Colon cancer originates in the large intestine, often progressing from benign polyps to malignant tumors. It ranges from early stage, localized cancers to advanced, metastatic disease.
Details →
Diabetes, a chronic condition impacting millions globally, disrupts blood sugar regulation, leading to complications like heart disease, kidney failure, and vision loss.
Details →
Testicular cancer, a rare but treatable malignancy, impacts young men most often, demanding innovative and effective solutions for lasting recovery.
Details →
Dendritic cell immunotherapy mobilizes dendritic cells, the immune system’s sentinels, to present leukemia-specific antigens to T-cells, sparking a precise attack on cancer cells.
Details →
Germany primarily utilizes adult stem cells offering therapies for conditions ranging from neurological and orthopedic disorders to autoimmune diseases and chronic wounds.
Details →
Germany emerges as a beacon of hope, leading the charge with dendritic cell therapy, a personalized immunotherapy that harnesses the body’s immune system to target cancer cells with precision.
Details →
On the other hand, melanoma arises from melanocytes, the pigment-producing cells in the skin, and is significantly more dangerous due to its tendency to spread rapidly to other parts of the body.
Details →
Bladder cancer originates in the urothelial cells lining the bladder, with ~75% of cases being non-muscle invasive bladder cancer (NMIBC), confined to the mucosa or submucosa.
Details →
Lyme disease, caused by the bacterium Borrelia burgdorferi and transmitted through infected tick bites, affects over 300,000 people annually in the USA alone.
Details →
Dementia encompasses disorders like Alzheimer’s disease (60–70% of cases), vascular dementia (caused by reduced brain blood flow), and frontotemporal dementia (affecting behavior and language).
Details →
Dendritic cell therapy is an advanced immunotherapy that harnesses dendritic cells, the immune system’s key antigen-presenting cells to trigger a targeted immune response against kidney cancer (renal cell carcinoma, RCC)
Details →
Prof. Dr. Frank Gansauge, with over 20 years of expertise in oncology and immunotherapy, is a pivotal figure in delivering personalized dendritic cell vaccine therapies in Germany.
Details →
Dendritic cell therapy is an advanced immunotherapy that utilizes dendritic cells, the immune system’s antigen-presenting cells, to stimulate a targeted immune response against colon cancer.
Details →
The HER2 protein drives tumor growth, making it a key target for targeted therapies for HER2 positive gastric cancer
Details →
Stage 4 stomach cancer, or metastatic gastric cancer, occurs when cancer cells spread beyond the stomach to distant organs such as the liver, lungs, or peritoneum, making treatment more complex
Details →
Colon cancer, a malignancy of the large intestine, is staged using the TNM system (Tumor, Node, Metastasis) to describe tumor size, lymph node involvement, and metastasis.
Details →
The latest stage 4 colon cancer treatment options in 2025 integrate advanced surgical techniques, systemic therapies, and experimental approaches, tailored to tumor biology and patient health.
Details →
Stage 4 rectal cancer is an advanced malignancy where cancer spreads from the rectum to distant organs such as the liver, lungs, bones, or peritoneum.
Details →
